Reinhold Schirmbeck

Title: Reinhold Schirmbeck: Innovator in Immunogenic Molecules

Introduction

Reinhold Schirmbeck is a notable inventor based in Krumbach, Germany. He has made significant contributions to the field of immunology, particularly through his innovative approaches to delivering immunogenic molecules.

Latest Patents

Schirmbeck holds a patent for the "Delivery of immunogenic molecules via HBsAg particles." This patent describes compositions of HBsAg particles that contain biologically active molecules. The methods outlined in the patent focus on stimulating enhanced immune responses. Notably, antigenic peptides contained in HBsAg particles were found to produce a cytotoxic T lymphocyte (CTL) response, which was not elicited by the peptide alone. The encapsulation of immunostimulating molecules, such as cytokines, significantly enhanced the CTL response evoked by the HBsAg particles themselves.

Career Highlights

Throughout his career, Schirmbeck has worked with various organizations, including Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work has been instrumental in advancing the understanding of immune responses and the development of immunotherapeutic strategies.

Collaborations

Schirmbeck has collaborated with notable colleagues, including Jörg Reimann and Yechezkel Barenholz. Their joint efforts have contributed to the advancement of research in immunology and related fields.

Conclusion

Reinhold Schirmbeck's innovative work in the delivery of immunogenic molecules has made a significant impact in the field of immunology. His contributions continue to influence research and development in immunotherapeutic strategies.